Inventor · disambiguated record
Kenneth Lyle Clark
Also filed as: CLARK KENNETH L · CLARK KENNETH LYLE
17 granted patents·10 pending applications·117 citations·filing 1978–2011
93Inventor score
Files withASTERAND UK LTD12AVENTIS PHARMA INC3CLARK KENNETH LYLE2BORMAN RICHARD A1BORMAN RICHARD ANTHONY1
Top patents by PatentIndex Score
27 records- 0191US7326732B2EP2 receptor agonistsPHARMAGENE LAB LTD·Filed 2005·Granted Feb 5, 2008·18 cites·8 claims
- 0289US7803841B2EP2 receptor agonistsASTERAND UK LTD·Filed 2008·Granted Sep 28, 2010·11 cites·13 claims
- 0387US6881555B2AKT nucleic acids, polypeptides, and uses thereofAVENTIS PHARMA INC·Filed 2000·Granted Apr 19, 2005·15 cites·50 claims
- 0486US7662839B2EP2 receptor agonistsASTERAND UK LTD·Filed 2007·Granted Feb 16, 2010·7 cites·15 claims
- 0584US7528157B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2006·Granted May 5, 2009·3 cites·24 claims
- 0684US7507754B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2007·Granted Mar 24, 2009·3 cites·41 claims
- 0781US7196089B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Mar 27, 2007·8 cites·30 claims
- 0877US7417068B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 26, 2008·8 cites·15 claims
- 0975US7569602B2Furan derivatives as EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 4, 2009·6 cites·13 claims
- 1074US4214917AProcess of forming a semiconductor memory cell with continuous polysilicon run circuit elementsEMM SEMI·Filed 1978·Granted Jul 29, 1980·34 cites·9 claims
- 1173US8080567B2EP2 receptor agonistsOXFORD ALEXANDER WILLIAM·Filed 2006·Granted Dec 20, 2011·2 cites·21 claims
- 1270US7989584B2AKT nucleic acids, polypeptides, and uses thereofAVENTIS PHARMA INC·Filed 2009·Granted Aug 2, 2011·0 cites·8 claims
- 1368US7858644B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2009·Granted Dec 28, 2010·0 cites·23 claims
- 1464US6998475B1Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathwayCENTELION SAS·Filed 2000·Granted Feb 14, 2006·1 cites·5 claims
- 1561US2008306117A1Ep4 receptor antagonistsASTERAND UK LTD·Filed 2008·Application pending·0 cites
- 1657US7662628B2Human Akt3 nucleic acid and uses thereofAVENTIS PHARMA INC·Filed 2005·Granted Feb 16, 2010·0 cites·8 claims
- 1756US7429607B25-HT2B receptor antagonistsASTERAND UK LTD·Filed 2003·Granted Sep 30, 2008·1 cites·16 claims
- 1855US7332593B2Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNFα) signaling pathwaySANOFI AVENTIS US LLC·Filed 2005·Granted Feb 19, 2008·0 cites·4 claims
- 1954US2012034188A1Akt Nucleic Acids, Polypeptides, and Uses ThereofGUO KUN·Filed 2011·Application pending·0 cites
- 2052US2010261760A1EP2 Receptor AgonistsASTERAND UK LTD·Filed 2010·Application pending·0 cites
- 2150US2008045596A1Ep2 Receptor AgonistsBORMAN RICHARD ANTHONY·Filed 2004·Application pending·0 cites
- 2250US2005209336A1EP2 receptor agonistsBORMAN RICHARD A·Filed 2004·Application pending·0 cites
- 2343US2012149731A1New medical useCLARK KENNETH LYLE·Filed 2010·Application pending·0 cites
- 2441US2009018150A15-Ht2b Receptor AntagonistsASTERAND UK LTD·Filed 2004·Application pending·0 cites
- 2540US2005154031A15-Ht2b receptor antagonistsFiled 2003·Application pending·0 cites
- 2636US2012157446A1Medical useCLARK KENNETH LYLE·Filed 2010·Application pending·0 cites
- 2734US2005176791A15-HT2B receptor antagonistsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Lyle Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →